Re-appointment of Mr. Santanu Mukherjee
RAINBOW · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rainbow Children's Medicare held its Board meeting on May 23, 2026, approving audited financial results for Q4 and FY2026 with an unmodified (clean) audit opinion from S.R. Batliboi & Associates. The Board recommended a final dividend of ₹3.5 per share (35% on ₹10 face value) for FY2026, payable after shareholder approval at the July 29 AGM, with record date July 21, 2026. Key leadership re-appointments were approved: Dr. Ramesh Kancharla as Chairman and Managing Director, Dr. Dinesh Kumar Chirla as Whole Time Director, and Mr. Santanu Mukherjee and Ms. Sundari Pisupati as Independent Directors — all for second terms of five years. Cost auditors M/s. Lavanya & Associates were also reappointed for FY2027.
The clean audit opinion and dividend recommendation indicate stable financial health, which should reassure investors. The continuity of key directors ensures leadership stability, though no major upside catalyst is present from this routine governance update.